You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for FDIC as Receiver for Signature Bridge Bank v. Concordia (S.D.N.Y. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in FDIC as Receiver for Signature Bridge Bank v. Concordia
The small molecule drugs covered by the patent cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for FDIC as Receiver for Signature Bridge Bank v. Concordia (S.D.N.Y. 2023)

Date Filed Document No. Description Snippet Link To Document
2023-10-24 21 Affidavit of Catherine Pastrikos Kelly in Opposition to Motion to Dismiss ACTOS (“584 patent”) and 6,329,404 (“404 patent”). The 584 and 404 drug product, “no ANDA filer would…to 404 patents and the method of use patents. Id. ¶ 144. Takeda's patents and to stay out…certification for those patents, i.e. fraudulently in obtaining a patent necessarily knows its patent either:…79,309 Where there are no applicable patents, or the patents have Generic manufacturers challenging…] on the ground that the patent does not covered by the brand's patents. See § 355(j) (2)(A) (viii External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.